These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38506485)

  • 1. A Benefit-Risk Conceptual Framework for Biologic Use During Pregnancy: A Mini-Review.
    Bozzi LM; Jacobson MH; Yost E; Sheahan A; Cafone J; Komatsu Y; Schwartz L; Levitan B; Nelson RM
    Clin Pharmacol Ther; 2024 Jun; 115(6):1251-1257. PubMed ID: 38506485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of biologics during pregnancy and risk of serious infections in the mother and baby: a Canadian population-based cohort study.
    Tsao NW; Lynd LD; Sayre EC; Sadatsafavi M; Hanley G; De Vera MA
    BMJ Open; 2019 Feb; 9(2):e023714. PubMed ID: 30787081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologic therapies and pregnancy: the story so far.
    Hyrich KL; Verstappen SM
    Rheumatology (Oxford); 2014 Aug; 53(8):1377-85. PubMed ID: 24352337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological effects and safety of live rotavirus vaccination after antenatal exposure to immunomodulatory biologic agents: a prospective cohort study from the Canadian Immunization Research Network.
    Fitzpatrick T; Alsager K; Sadarangani M; Pham-Huy A; Murguía-Favela L; Morris SK; Seow CH; Piché-Renaud PP; Jadavji T; Vanderkooi OG; Top KA; Constantinescu C;
    Lancet Child Adolesc Health; 2023 Sep; 7(9):648-656. PubMed ID: 37390832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccines in Children Exposed to Biological Agents In Utero and/or During Breastfeeding: Are They Effective and Safe?
    Gisbert JP; Chaparro M
    J Crohns Colitis; 2023 Jun; 17(6):995-1009. PubMed ID: 36652274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suboptimal Vaccination Administration in Mothers With Inflammatory Bowel Disease and Their Biologic-Exposed Infants.
    Chiarella-Redfern H; Lee S; Jubran B; Sharifi N; Panaccione R; Constantinescu C; Benchimol EI; Seow CH
    Inflamm Bowel Dis; 2022 Jan; 28(1):79-86. PubMed ID: 33609034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel Disease.
    Mahadevan U; Long MD; Kane SV; Roy A; Dubinsky MC; Sands BE; Cohen RD; Chambers CD; Sandborn WJ;
    Gastroenterology; 2021 Mar; 160(4):1131-1139. PubMed ID: 33227283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of Biologic Therapy in Older Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis.
    Borren NZ; Ananthakrishnan AN
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1736-1743.e4. PubMed ID: 30616024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis.
    Singh JA; Hossain A; Tanjong Ghogomu E; Mudano AS; Maxwell LJ; Buchbinder R; Lopez-Olivo MA; Suarez-Almazor ME; Tugwell P; Wells GA
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012591. PubMed ID: 28282491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psoriasis in pregnancy: a review (II).
    Ruiz V; Manubens E; Puig L
    Actas Dermosifiliogr; 2014 Nov; 105(9):813-21. PubMed ID: 24314892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From mother to baby: antenatal exposure to monoclonal antibody biologics.
    Pham-Huy A; Sadarangani M; Huang V; Ostensen M; Castillo E; Troster SM; Vaudry W; Nguyen GC; Top KA
    Expert Rev Clin Immunol; 2019 Mar; 15(3):221-229. PubMed ID: 30570400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antirheumatic biologics in pregnant patients: a call for studies to address the knowledge gap.
    Østensen M
    Expert Rev Clin Immunol; 2018 Feb; 14(2):95-97. PubMed ID: 29297701
    [No Abstract]   [Full Text] [Related]  

  • 14. Biologic agents in the treatment of glomerulonephritides.
    Yeo SC; Liew A
    Nephrology (Carlton); 2015 Nov; 20(11):767-87. PubMed ID: 26040770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient Understanding of the Risks and Benefits of Biologic Therapies in Inflammatory Bowel Disease: Insights from a Large-scale Analysis of Social Media Platforms.
    Martinez B; Dailey F; Almario CV; Keller MS; Desai M; Dupuy T; Mosadeghi S; Whitman C; Lasch K; Ursos L; Spiegel BMR
    Inflamm Bowel Dis; 2017 Jul; 23(7):1057-1064. PubMed ID: 28410343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rheumatoid arthritis and pregnancy: impediments to optimal management of both biologic use before, during and after pregnancy.
    Williams M; Chakravarty EF
    Curr Opin Rheumatol; 2014 May; 26(3):341-6. PubMed ID: 24663107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 1: Live Vaccines.
    Benchimol EI; Tse F; Carroll MW; deBruyn JC; McNeil SA; Pham-Huy A; Seow CH; Barrett LL; Bessissow T; Carman N; Melmed GY; Vanderkooi OG; Marshall JK; Jones JL
    Gastroenterology; 2021 Aug; 161(2):669-680.e0. PubMed ID: 33617891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of biologic agents in pregnancy and breastfeeding.
    Horst S; Kane S
    Gastroenterol Clin North Am; 2014 Sep; 43(3):495-508. PubMed ID: 25110255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The new biologics in pregnancy.
    Pupco A
    J Popul Ther Clin Pharmacol; 2014; 21(3):e548-54. PubMed ID: 25527794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of biologics and small molecules in pregnant patients with rheumatic diseases.
    Gerosa M; Argolini LM; Artusi C; Chighizola CB
    Expert Rev Clin Pharmacol; 2018 Oct; 11(10):987-998. PubMed ID: 30227748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.